| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Michael Messinger is Chief Financial Officer at ICU and has filed Form 4s across 2 companies. Michael Messinger's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $35K at current prices.
The biggest single holding is ICU (~$35K) as Chief Financial Officer. Net of sales, the ICU filings show accumulation of 14,500 shares.
Michael Messinger has 2 Form 4 filings on record from December 2025 to August 2026, across 2 companies: Chief Financial Officer at SeaStar Medical (ICUCW), 2026; Chief Financial Officer at SeaStar Medical (ICU), 2025.
The 2 reported transactions were 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $8K and no sales.
The largest open-market purchase was 14,500 shares of ICU at an average $0.35 on December 9, 2025, about $5K.